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We previously identiﬁed HSP70 and HSC70 in complex with NS5A in a proteomic screen. Here,
coimmunoprecipitation studies conﬁrmed NS5A/HSC70 complex formation during infection, and
immunoﬂuorescence studies showed NS5A and HSC70 to colocalize. Unlike HSP70, HSC70 knockdown
did not decrease viral protein levels. Rather, intracellular infectious virion assembly was signiﬁcantly
impaired by HSC70 knockdown. We also discovered that both HSC70 nucleotide binding and substrate
binding domains directly bind NS5A whereas only the HSP70 nucleotide binding domain does. Knock-
down of both HSC70 and HSP70 demonstrated an additive reduction in virus production. This data
suggests that HSC70 and HSP70 play discrete roles in the viral life cycle. Investigation of these different
functions may facilitate developing of novel strategies that target host proteins to treat HCV infection.
& 2014 Elsevier Inc. All rights reserved.
Introduction
The hepatitis C virus (HCV) infects 3% of the world population
and is mainly responsible for liver transplantation in patients with
cirrhosis in developed countries (Shepard et al., 2005). Furthermore,
HCV is the most common chronic blood borne pathogen in the
United States (US) affecting 1.8% of the population and is the major
etiologic factor responsible for the recent doubling of hepatocellular
carcinoma (HCC) (El-Serag, 2002).
HCV infection is currently treated by the combination of pegy-
lated interferon-α (PEG-IFN), ribavirin, and the recently approved
NS3/4A protease inhibitors which have led to an increased sustained
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virological response (SVR) compared with PEG-IFN and ribavirin
alone, but also increased adverse events including anemia and
gastrointestinal symptoms (Ciesek and Manns, 2011). Nevertheless,
a signiﬁcant number of patients cannot receive these treatments as
they require PEG-IFN. For these reasons, there is the need to develop
adjunct or replacement therapies that are less toxic and more
efﬁcacious in terms of higher SVR rates and HCC prevention.
HCV is an RNA virus classiﬁed in the genus Hepacivirus in the
Flavivirus family and possesses an approximately 10 kb positive sense
RNA genome. The 5' non-coding region (NCR) of the viral genome
possesses an internal ribosomal entry site (IRES) (Wang et al., 1993), a
cis-acting element found in some host RNA transcripts as well as in
viruses that allow ribosomal translation initiation to occur internally
within a transcript in lieu of 5' cap dependent translation (Pacheco
and Martinez-Salas, 2010). The HCV viral life cycle in a cell can be
divided into six phases: (1) binding and internalization, (2) cytoplas-
mic release and uncoating, (3) viral polyprotein translation and
processing, (4) RNA genome replication, (5) packaging and assembly,
and (6) virus morphogenesis and secretion (Moradpour et al., 2007).
The viral non-structural protein 5A (NS5A), a 56–59 kDa phos-
phoprotein, is a multi-functional protein and a component of the
viral replicase complex. It has been implicated in regulation of HCV
genome replication, IRES-mediated viral protein translation, virion
assembly, and infectious virion secretion (He et al., 2003; Hughes
et al., 2009; Khachatoorian et al., 2012a, 2012b; Tellinghuisen et al.,
2008).
Interestingly, cellular heat-shock proteins (HSPs) play an impor-
tant role in the replication of RNA viruses (Vasconcelos et al., 1998;
Weeks and Miller, 2008; Zheng et al., 2010). HSPs, which normally
assist unfolded or mis-folded polypeptide chains to (re)fold into
functional proteins, are crucial for cell survival during stressful
conditions (Mayer and Bukau, 2005). We have previously identiﬁed,
through coimmunoprecipitation and subsequent mass spectrometric
analyses, an NS5A/HSP complex composed of NS5A, HSP70, and
HSP40 (cofactor of HSP70) and demonstrated their colocalization in
huh-7 cells (Gonzalez et al., 2009). We further showed that both
NS5A-augmented IRES-mediated translation and virus production
are blocked by (1) HSP70 knockdown, (2) the HSP synthesis inhibitor
quercetin, a bioﬂavonoid, and (3) a small peptide from NS5A domain I
that is capable of blocking NS5A/HSP70 interaction, with no
associated cytotoxicity (Gonzalez et al., 2009; Khachatoorian
et al., 2012a, 2012b). These ﬁndings support our hypothesis that
HCV utilizes an NS5A/HSP complex to facilitate IRES-mediated
translation of its genome.
Our mass spectrometric analyses also identiﬁed heat shock
cognate protein 70 (HSC70) in complex with NS5A (Gonzalez et al.,
2009). HSC70, a crucial housekeeping gene, is the constitutively
expressed homolog of HSP70 that bears signiﬁcant (86%) homol-
ogy to HSP70 (Daugaard et al., 2007). It has been reported that
HSC70 is a component of the viral particle and its downregulation
signiﬁcantly reduces virus production (Parent et al., 2009). Either
modulation of assembly or viral secretion was implicated in this
report.
In this study, we sought to further analyze the binding of HSC70
and NS5A biochemically and to examine various phases of the viral
life cycle to identify the speciﬁc step(s) that requires HSC70 during
viral proliferation.
Results
HSC70 directly binds NS5A in vitro
In our previous report, we described the identiﬁcation, through
mass spectrometric analyses, of a number of host HSPs, including
HSP70 (speciﬁcally the HSPA1A gene) and HSC70 (HSPA8 gene), in
complex with the viral NS5A protein (Gonzalez et al., 2009). We
have also reported that HSP70 directly binds NS5A through a
hairpin peptide at the C terminus of NS5A domain I to form a
complex that is required for IRES-mediated viral protein transla-
tion (Khachatoorian et al., 2012b).
Considering the signiﬁcant homology between HSC70 and HSP70,
we proceeded to analyze the NS5A/HSC70 interaction biochemically.
Recombinant full-length HSC70 and full-length NS5A were expressed
in and puriﬁed from bacteria and were tested for binding through
surface plasmon resonance (SPR) analyses. Both proteins were
expressed in fusion with maltose binding protein (MBP). Full-length
NS5A was immobilized on the SPR chip, and HSC70 was injected at
different concentrations to assay its binding. As negative control for
NS5A binding, human serum albumin (HSA) was injected at the same
concentrations. The binding signal for HSA was subtracted from
HSC70 binding in order to set HSA binding signal to zero response
units, and the resultant HSC70 signal was plotted. As shown in Fig. 1A,
HSC70 directly bound NS5A, and the dissociation constant was
determined to be 2.22106.
NS5A is known to be a promiscuous protein that can bind to
multiple host proteins. To further conﬁrm that the observed
interaction between HSC70 and NS5A is speciﬁc, we randomly
selected human insulin as a negative control for binding to NS5A.
Different concentrations of human insulin were tested for NS5A
interaction. As shown in Fig. 1B, no signiﬁcant interaction above
background binding was observed between insulin and NS5A. We
also tested the binding of insulin to HSP70 and did not see any
interaction (Fig. 1C).
The NS5A/HSC70 interaction is mediated with both the nucleotide
binding domain (NBD) and the substrate binding domain (SBD) of
HSC70
We previously showed that the NS5A/HSP70 interaction is
mediated by the NBD of HSP70 (Khachatoorian et al., 2012b).
To further characterize the NS5A/HSC70 interaction, we also expressed
and puriﬁed recombinant MBP-fusion HSC70-NBD (N-terminal) and
HSC70-SBD (the entire C-terminal fragment of HSC70) and tested
them in SPR assays for binding to full-length NS5A as above. We found
that NS5A directly binds both HSC70-NBD and HSC70-SBD (Fig. 1D
and E), and the dissociation constants were determined to be
2.9106 for HSC70-NBD and 7.54106 for HSC70-SBD.
HSC70 and HSP70 do not bind each other directly in vitro
Considering the fact that both HSC70 and HSP70 directly bind
NS5A and that both of these HSPs were found as NS5A binding
proteins in our mass spectrometric analyses, we proceeded to
examine the possibility that HSC70 and HSP70 could directly bind
each other and potentially be involved in the formation of NS5A
complex(es) with HSPs. We expressed recombinant full-length
HSP70 (not in fusion with MBP) and tested its interactionwith full-
length HSC70 and its NBD and SBD. As shown in Fig. 1F–H, no
interaction was detected between any of the HSC70 and HSP70
protein constructs. We also tested the binding of all HSC70
constructs with MBP-fusion HSP70-NBD and obtained similar
results indicating no binding (data not shown).
HSC70 binds NS5A in vivo
After demonstrating a direct interaction between recombinant
HSC70 and NS5A in vitro, we proceeded to determine whether this
interaction occurs in vivo in the HCV cell culture (HCVcc) system.
Huh-7.5 cells were infected for 72 h. Subsequently, the infected
cells and the control uninfected cells were harvested. The lysates
were subjected to immunoprecipitation with antibody against
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Fig. 1. HSC70 directly binds NS5A in vitro through both its nucleotide binding domain (NBD) and substrate binding domain (SBD) and does not bind HSP70. All panels display
surface plasmon resonance (SPR) analyses. The immobilized and injected proteins are indicated in ﬁgure legends. For all assays, the injection time is 180 s followed by 180 s
of dissociation. In panels (A) and (D–H), the binding signal for human serum albumin (HSA) (negative control) is subtracted from the binding of HSC70 constructs (i.e. HSA
binding is set at zero response units). (A) Full-length HSC70 directly binds NS5A. (B) Human insulin does not bind to NS5A. (C) Human insulin does not bind HSP70.
(D) HSC70-NBD directly binds NS5A. (E) HSC70-SBD directly binds NS5A. (F) Full-length HSC70 does not bind HSP70. (G) HSC70-NBD does not bind HSP70. (H) HSC70-SBD
does not bind HSP70.
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HSC70 and the corresponding IgG as negative control, and the
presence of coimmunoprecipitated NS5A was assays by Western
analyses with antibody against NS5A. As shown in Fig. 2, NS5Awas
coimmunoprecipitated from infected cells with antibody
against HSC70.
HSC70 and HSP70 do not bind each other in vivo
The presence of HSP70 in the above coimmunoprecipitation
assay was assayed by Western analyses with antibody against
HSP70, and no coimmunoprecipitated HSP70 was detected in the
infected cells (Fig. 2).
HSC70 and NS5A colocalize in vivo
After conﬁrming the NS5A/HSC70 interaction in vivo biochemi-
cally, we further investigated this interaction in vivo by performing
immunoﬂuorescence analyses in infected cells. Cells were infected
for 48 h and immunoﬂuorescence was performed by antibodies
against HSC70 and NS5A. As shown in Fig. 3, NS5A almost entirely
colocalized with HSC70 (M1¼0.9766), and HSC70 mostly coloca-
lized with NS5A as well (M2¼0.7161).
RNAi-mediated knockdown of HSC70
In this study, we utilized siRNA against HSC70 (HSPA8 gene) to
examine the role of HSC70 during viral proliferation. HSC70 is a
very important housekeeping gene, so we ﬁrst sought to determine
if we could signiﬁcantly knockdown HSC70 in our cell culture
system with no cytotoxicity. Huh-7.5 cells were treated with siRNAs
against HSC70, HSP70 (speciﬁcally the HSPA1A gene examined in
our previous reports (Gonzalez et al., 2009; Khachatoorian et al.,
2012a, 2012b)), or both or their corresponding control siRNAs,
and MTT assays were performed every 24 h up to 96 h. (The siRNAs
against HSC70 and HSP70 were obtained from different companies
and, therefore, required their own control siRNAs.) As shown in
Fig. 4A, no cytotoxicity was observed up to 96 h after siRNA
treatment. As control, treatment with luteolin (a potential anti-
cancer drug) resulted in excessive cellular toxicity (Fig. 4A). Knock-
down of both HSC70 and HSP70 also did not result in any detectable
cytotoxicity (Fig. 4A).
Subsequently, we performed Western analyses to determine
the levels of HSC70 protein after siRNA treatment. A signiﬁcant
reduction in HSC70 protein levels was observed with HSC70 siRNA
treatment (Fig. 4B and C). Interestingly, we observed upregulation
of HSP70 with HSC70 knockdown (Fig. 4B and C). As control,
knockdown of HSP70 abolished HSP70 protein (Fig. 4B and C).
Simultaneous knockdown of both HSC70 and HSP70 also resulted
in signiﬁcant reduction of HSC70 and eliminated HSP70 protein
(Fig. 4B and C).
Knockdown of HSC70 signiﬁcantly decreases HCV production
Next, we tested the anti-viral effects of HSC70 knockdown in
the HCVcc system. Huh-7.5 cells were treated with siRNAs against
HSC70, HSP70 or both as well as their corresponding control
siRNAs. Cells were infected with the Renilla reporter virus and
luciferase activity determined.
Knockdown of HSC70 resulted in a signiﬁcant decrease in
intracellular virus in agreement with previously reported results
(Parent et al., 2009) (Fig. 5A). As expected, knockdown of HSP70
also attenuated intracellular virus as reported before (Gonzalez
et al., 2009) (Fig. 5A). Importantly, simultaneous knockdown of
HSC70 and HSP70 resulted in lower levels of intracellular virus
compared with individual knockdowns (Fig. 5A). These results
indicate potentially additive effects of knockdown of HSC70 and
HSP70 and suggest that HSC70 and HSP70 have differential
functions within the HCV life cycle.
Levels of viral secretion were also determined by infecting naïve
cells with the supernatants of the above cell culture. As shown in
Fig. 5B, individual knockdowns of HSC70 and HSP70 resulted in
signiﬁcant reduction of infectious virus production. However, the
decrease in virus production observed with knockdown of HSC70
was much more than the effects of HSP70 knockdown. In addition,
knockdown of both HSC70 and HSP70 resulted in a dramatic (over
95%) reduction in virus production again demonstrating additive
effects (Fig. 5B).
To verify knockdown of HSC70 and HSP70 and their effects on
virus production, we also utilized short hairpin RNA (shRNA)
against HSC70 and HSP70 and obtained similar target knockdown
(Fig. 6A and B) and subsequent effects on virus production (Fig. 6C).
HSC70 is not involved in HCV RNA replication
After achieving a signiﬁcant decrease in virus production by
HSC70 knockdown, we proceeded to determine the speciﬁc phase
(s) of viral life cycle affected by knockdown of HSC70 using the
HCVcc system. Cells were infected for 24 h (to limit the duration of
the assay to one viral life cycle), at which point the cells were
harvested and the levels of positive strand viral RNA were
determined by quantitative reverse transcriptase PCR (qRT-PCR).
As shown in Fig. 7A, knockdown of HSC70 did not reduce viral
RNA levels compared with the corresponding control siRNA
treatment. Instead, a slight, but statistically signiﬁcant increase
in viral RNA levels was observed. We believe that this increase
may be due to increased viral proteins secondary to the compen-
satory increase in HSP70 (resulting in increased IRES mediated
viral protein translations) seen with HSC70 knockdown (Figs. 4B
and C, and 6A and B). However, as shown in Fig. 7A, knockdown of
HSP70 resulted in a signiﬁcant decrease in viral RNA levels
potentially due to decreased viral protein translation as reported
previously (Gonzalez et al., 2009) and in this study (see below).
As a negative control, treatment of cells with Brefeldin A (a known
inhibitor of secretion (Goldwasser et al., 2011)) did not affect
viral RNA levels, while treatment with 2'-C-methyl-cytidine,
a previously reported inhibitor of the viral NS5B polymerase
(Le Pogam et al., 2006), signiﬁcantly decreased viral RNA replica-
tion levels (Fig. 7A).
HSC70 is not involved in regulating NS5A-augmented IRES-mediated
translation
We also determined the levels of NS5A-augmented IRES-
mediated translation in a previously described virus-free cell
culture-based bicistronic reporter system (Gonzalez et al., 2009).
This reporter consists of a Renilla luciferase (RLuc) open reading
frame (ORF) and a Fireﬂy luciferase (FLuc) ORF driven by a 5'-cap
Fig. 2. HSC70 interacts with NS5A in vivo. Coimmunoprecipitation assay demon-
strates that HSC70 binds NS5A in infected cells. Huh-7.5 cells were infected for 72 h
and harvested. Cell lysates from infected and uninfected control cells were
immunoprecipitated with antibody against HSC70 followed by Western analysis.
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and the HCV IRES, respectively (Fig. 7B). The ratio of Fireﬂy to
Renilla luciferase values (FLuc/RLuc) reﬂects the levels of HCV
IRES-mediated translation. We have previously shown that knock-
down of HSP70 as well as treatment with quercetin, an HSP
synthesis inhibitor, decreases the NS5A-driven increase in IRES-
mediated translation (Gonzalez et al., 2009; Khachatoorian et al.,
2012a).
As expected, knockdown of HSP70 dramatically inhibited the
NS5A-driven IRES activity (Fig. 7C). Treatment with HSC70 siRNA,
however, did not inhibit, but resulted in a slight increase in NS5A-
augmented IRES-mediated translation in agreement with the
results of viral protein production assays below (Fig. 8).
HSC70 is not involved in viral protein production
To determine the effect of HSC70 on viral protein production,
following siRNA treatment, cells were infected up to 28 h, and
intracellular viral protein production was determined at several
time points during the 28 h infection window. As shown in Fig. 8A,
treatment with the control siRNAs resulted in a steady increase
in viral protein levels during the ﬁrst 24 h followed by a large
increase after 24 h at time point 28 similar to our previously
reported results (Khachatoorian et al., 2012a) suggesting that the
duration of viral life cycle is approximately 24 h.
As expected, treatment with HSP70 siRNA decreased viral
protein levels throughout the time course (Fig. 8). This is in
agreement with our previously reported data implicating HSP70
in regulating viral translation (Gonzalez et al., 2009; Khachatoorian
et al., 2012a, 2012b). A signiﬁcant reduction in viral protein levels
was also observed after the ﬁrst 24 h with knockdown of HSP70
(Fig. 8).
Treatment with HSC70 siRNA, on the other hand, did not
decrease intracellular viral protein levels; instead, a slight, but
statistically signiﬁcant increase was observed (Fig. 8). As men-
tioned above, this could be caused by a compensatory effect of
increased HSP70 levels in response to HSC70 knockdown. Intra-
cellular viral protein production, however, was reduced after the
ﬁrst 24 h indicating a decrease in the levels of secreted virions
which results in infection of fewer cells after the ﬁrst viral life
cycle (Fig. 8A).
We considered the possibility that the compensatory upregula-
tion of HSP70 caused by knockdown of HSC70 could mask a
potential role for HSC70 in viral protein translation. To address this
possibility, we also simultaneously knocked down both HSC70 and
HSP70, thereby eliminating the compensatory upregulation of
Fig. 3. HSC70 colocalizes with NS5A in vivo. Immunoﬂuorescence assay demonstrates colocalization of HSC70 and NS5A in vivo. Huh-7.5 cells were infected for 48 h followed
by simultaneous immunoﬂuorescence staining with antibodies against HSC70 and NS5A. (A) HSC70 (blue). (B) NS5A (red). (C) Immunoﬂuorescence staining for both HSC70
and NS5A (pink). (D) Scatter plot demonstrating the colocalization of HSC70 and NS5A. (E) Table indicating Manders overlap coefﬁcients for colocalization of HSC70 with
NS5A (M1) and colocalization of NS5A with HSC70 (M2). Overlap analyses were done on four independent immunoﬂuorescence experiments.
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HSP70. As shown in Fig. 8, knockdown of both HSC70 and HSP70
resulted in decreased viral protein levels during the ﬁrst 24 h
similar to knockdown of HSP70 alone. Furthermore, there is a
highly signiﬁcant decrease in viral protein levels after 24 h com-
pared with each individual knockdown. These observations suggest
that HSC70 and HSP70 have distinct roles in the viral life cycle and
that HSC70 is unlikely to be involved in viral protein translation.
The fact that viral RNA levels are not decreased by HSC70 as well
as the interesting observation that viral protein levels decrease after
one viral life cycle despite no decrease during the life cycle strongly
suggested to us that HSC70 is involved in regulating point(s) of viral
life cycle after viral protein translation, i.e. virion assembly or viral
secretion.
Knockdown of HSC70 signiﬁcantly impairs intracellular infectious
virion assembly
We next determined the effect of knockdown of HSC70 on viral
assembly. Following siRNA treatment and infection, intracellular
infectious virus was obtained by freeze/thaw treatment and used
to infect naïve cells. As shown in Fig. 9A, levels of intracellular
infectious virions were reduced by RNAi-mediated knockdown of
HSC70 and HSP70. In contrast to the intracellular infectious virus
results, a slight increase in viral protein levels was seen with
knockdown of HSC70, whereas protein levels were reduced with
HSP70 knockdown (Fig. 8B and data not shown). These results
implicate HSC70 in viral assembly and the decreased infectious
intracellular virus seen with HSP70 is likely to be related to
lowered viral protein rather than a direct effect on assembly.
We also collected secreted virus in a 5-hour window of time,
determined the levels of secreted virus, and obtained similar
results to the above assembly assay (Fig. 9B). These results strongly
suggest that the decrease in levels of secreted virus observed with
knockdown of HSC70 is most likely caused by an assembly defect
rather than a secretion defect.
Discussion
We have previously identiﬁed HSC70 to be part of a complex of
proteins that include NS5A and host proteins HSP70 and HSP40
(Gonzalez et al., 2009). We have demonstrated the signiﬁcance of
the NS5A/HSP70 interaction for its role in HCV IRES-mediated
translation (Gonzalez et al., 2009; Khachatoorian et al., 2012a,
2012b). Considering the signiﬁcant homology between HSP70 and
HSC70, we have been highly interested in further studying the
NS5A/HSC70 interaction. It has also been reported that HSC70 is
part of the HCV viral particles, and HSC70 was implicated in
modulation of assembly or secretion (Parent et al., 2009). In this
study, we further analyzed the NS5A/HSC70 interaction biochemi-
cally and conducted detailed analyses of the role of HSC70 in
various phases of the viral life cycle.
Our lab and others have previously shown the NS5A/HSC70
interaction (Chen et al., 2010; Gonzalez et al., 2009). Due to the use
of cellular systems, however, it was not determined whether NS5A
directly binds HSC70. In this study, we have shown for the ﬁrst
Fig. 4. siRNA-mediated knockdown of HSC70 is not cytotoxic to cells. (A) MTT assay
demonstrates that knockdown of HSC70 does not have any cytotoxic effects at 96 h
after siRNA transfection. (B) Western analysis of cells treated with the above
siRNAs. (C) Densitometry of the Western blot in panel B.
Fig. 5. siRNA-mediated knockdown of HSC70 signiﬁcantly decreases virus produc-
tion. (A) Intracellular virus production assay demonstrates that knockdown of
HSC70 results in a signiﬁcant decrease in intracellular virus levels. (B) Long term
infectious virion secretion assay indicates that knockdown of HSC70 dramatically
reduced infectious virion secretion.
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time that HSC70 directly binds NS5A in vitro through surface
plasmon resonance (SPR) analyses utilizing puriﬁed recombinant
proteins, suggesting that no other viral or host protein is required
for the NS5A/HSC70 interaction. We have further conﬁrmed the
NS5A/HSC70 interaction in vivo by performing coimmunoprecipi-
tation assays on infected cells where we were able to successfully
pull down NS5A with antibody against HSC70. We also demon-
strated that NS5A and HSC70 colocalize in infected cells in vivo by
immunoﬂuorescence analyses.
We further showed, through SPR analyses, that both the
nucleotide binding domain (NBD) and the substrate binding
domain (SBD) of HSC70 directly bind NS5A in contrast with the
HSP70 interaction with NS5A which we have previously shown to
involve HSP70-NBD alone (Khachatoorian et al., 2012b). We
speculate that this difference is caused by the fact that while
HSC70 and HSP70 are 86% identical to each other, the C terminus
of the HSP70 family of proteins bear the least homology to each
other (Daugaard et al., 2007). We are currently investigating the
direct binding of the three NS5A domains to HSC70 to better
understand the mechanism of this interaction.
To ﬁnd out whether HSC70 and HSP70 could directly bind each
other and be potentially involved in the formation of NS5A
complex(es) with heat shock proteins, we utilized SPR analyses
and did not ﬁnd any interaction between HSC70 and HSP70
in vitro. In addition, we did not detect any interaction between
HSC70 and HSP70 in infected cells in vivo as no HSP70 was
detected in our coimmunoprecipitation analyses with antibody
against HSC70. These ﬁndings are in agreement with our identi-
ﬁcation of the distinct roles of HSC70 and HSP70 within the viral
life cycle in this report and previously (Gonzalez et al., 2009) and
further suggest that the NS5A/HSC70 and the NS5A/HSP70 com-
plexes form independently of each other to facilitate different
functions within different stages of the viral life cycle.
Fig. 6. shRNA-mediated knockdown of HSC70 signiﬁcantly decreases virus produc-
tion. (A) Western analysis of cells treated with shRNAs against HSC70, HSP70, or
both. (B) Densitometry of the Western blot in panel (A). (C) Intracellular virus
production assay demonstrates that knockdown of HSC70 results in a signiﬁcant
decrease in intracellular viral levels.
Fig. 7. Knockdown of HSC70 does not affect viral RNA replication and NS5A-
augmented IRES-mediated translation. (A) Quantitative reverse transcriptase PCR
(qRT-PCR) analysis indicates that knockdown of HSC70 does not affect viral RNA
replication. (B) Schematic of the bicistronic reporter construct used in the dual
luciferase assays in part (C). This construct contains the Renilla luciferase and Fireﬂy
luciferase ORFs under the control of a 5'-cap and the HCV IRES, respectively.
The ratio of Fireﬂy to Renilla measurements is indicative of IRES-mediated
translation. (C) IRES assay indicates that knockdown of HSC70 does not decrease
NS5A-augmented IRES-mediated translation.
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We determined the anti-viral activity of HSC70 knockdown in
our HCV cell culture (HCVcc) system utilizing the Renilla reporter
virus. Knockdown of HSC70 resulted in a signiﬁcant decrease in
virus production which was comparable to the reduction of virus
production observed by knockdown of HSP70 in this study and
before (Gonzalez et al., 2009). Considering the signiﬁcant homol-
ogy between HSC70 and HSP70 and their potential compensatory
regulation as seen in Fig. 4B and 6A, we asked whether knock-
down of HSC70 or HSP70 displays anti-viral effects by affecting the
same or different phase(s) of viral life cycle. We reasoned that if
HSC70 and HSP70 are involved in regulating different phase(s) of
viral life cycle, we would expect to see an additive anti-viral effect
if both HSC70 and HSP70 are knocked down, whereas no sig-
niﬁcant additive effect should be expected otherwise. Simulta-
neous knockdown of both HSC70 and HSP70 indeed displayed a
dramatic and additive inhibitory effect suggesting that they
potentially play distinct roles in the viral life cycle.
To obtain further insights into the role of HSC70 and HSP70 in
the viral life cycle, we measured secreted virus levels. These
results revealed that knockdown of HSC70 impacts secretion
signiﬁcantly more than knockdown of HSP70 in contrast with
the intracellular virus levels. This occurs despite signiﬁcant upre-
gulation of HSP70 as a result of knockdown of HSC70 indicating
distinct functions for HSC70 and HSP70 during the viral life cycle.
Intracellular infectious virion assembly was signiﬁcantly inhib-
ited by knockdown of HSC70. Knockdown of HSP70 also resulted
in a signiﬁcant decrease in intracellular infectious virus levels
most likely due to decreased viral protein production levels. We
considered the possibility that HSC70 may play a role in earlier
stages of viral life cycle, (i.e. viral genome replication and viral
protein translation), which may be masked by the upregulation of
HSP70 due to knockdown of HSC70. Viral protein translation levels
signiﬁcantly increased with knockdown of HSC70, which we
attribute to the compensatory increase in HSP70 levels seen by
HSC70 knockdown. However, we observed that simultaneous
knockdown of HSC70 and HSP70 does not display the compensa-
tory upregulation of HSP70 and results in decreased viral transla-
tion similar to knockdown of HSP70 alone suggesting that HSC70
likely does not play a role in viral protein translation. The results of
double knockdown of HSC70 and HSP70 also suggest that viral
genome replication is also unlikely to be mediated by HSC70. If
HSC70 was involved in viral genome replication, we would expect
to observe a higher impact on viral protein translation levels with
double knockdown of HSC70 and HSP70. Thus, our results are
consistent with the notion that while HSP70 plays a role in viral
translation, HSC70 most likely is involved in the assembly of
infectious virus particles.
These ﬁndings as well as the fact that HSC70 and HSP70 are
host proteins open up potential therapeutic avenues to treat HCV
infection by targeting host proteins as opposed to viral proteins to
minimize the development of resistance.
Materials and methods
Plasmid constructs
All recombinant proteins were cloned in the pET-28b plasmid
(Novagen, 69865-3). The HCV IRES reporter plasmid and the NS5A
Fig. 8. Knockdown of HSC70 does not affect intracellular viral protein production.
(A) Intracellular viral protein production assay indicates that knockdown of HSC70
does not decrease intracellular viral protein production. Huh-7.5 cells were treated
with siRNAs against HSC70, HSP70, or their corresponding control siRNAs and
infected with the reporter virus 24 h later. At the indicated time points after
infection, cells were harvested and luciferase activity was measured. (B) Bar graph
corresponding to the 24 h time point of the above assay.
Fig. 9. Knockdown of HSC70 signiﬁcantly reduces intracellular infectious virion
assembly. (A) Intracellular infectious virion assembly assay demonstrates that
knockdown of HSC70 signiﬁcantly inhibits virion assembly. (B) Short term
infectious virion secretion assay demonstrates the effect of knockdown of HSC70
on virus secretion.
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and GFP retroviral expression vectors pMSCV-NS5A-FLAG and pMSCV-
GFP, respectively, have been previously described (Gonzalez et al.,
2009). An intragenotype 2 chimeric monocistronic reporter virus,
pNRLFC based on pJ6/JFH-C parental virus has been described pre-
viously (Arumugaswami et al., 2008). For the current study, we have
used a chemically synthesized plasmid pFNX-RLuc (having similar
sequences to pNRLFC) for construction of recombinant virus.
Production and puriﬁcation of recombinant proteins
All proteins were expressed and puriﬁed as described previously
(Wheatley et al., 2013). Brieﬂy, protein expression was induced with
1 mM IPTG in BL21(DE3) Escherichia coli cells, shaking at 250 rpm,
for 5 h at 37 1C. Cells were centrifuged for 5 min at 6000 rpm and
stored at 20 1C. Cells were resuspended in 50 mM Tris–HCl pH
7.6, 300 mM NaCl, and 20 mM imidazole, with Protease Inhibitor
Cocktail (Sigma-Aldrich, P8849-5ml) and lysed by sonication. Cells
were spun down in rotor SS-34 at 16,500 rpm for 30 min, ﬁltered
through a 0.2 μm ﬁlter, and applied to a Hi-trap Nickel column by a
syringe at room temperature. Proteins were eluted in one step with
50 mM Tris–HCl pH 7.6, 300 mM NaCl, and 400 mM imidazole.
Surface plasmon resonance (SPR)
Binding studies were performed on a Biacore 3000 instrument
(Biacore AB, Uppsala, Sweden). Proteins were immobilized on CM5
sensor chips by amine coupling. The solution phase analytes
were dissolved in HBS-EP buffer, which contained 0.15 M NaCl,
10 mM HEPES, pH 7.4, 3 mM EDTA, and 0.005% polysorbate 20. The
solutions traversed the sensors at a ﬂow rate of 50 ml/min. Costar
low-retention polypropylene tubes (Corning, 3207) were used
throughout. Binding results were expressed in resonance units.
Kinetics and dissociation constants were analyzed and calculated
with BIAevaluation Software Version 4.1.
Cell culture
Cell lines huh-7.5, SGR (an HCV subgenomic replicon harboring
cell line), and 293T were maintained in a humidiﬁed atmosphere
containing 5% CO2 at 37 1C in Dulbecco's Modiﬁed Eagle Medium
(Mediatech, 10-013-CM) supplemented with 10% fetal bovine serum
(Omega Scientiﬁc, FB-01) and 2mM L-glutamine (Life Technologies,
25030). Huh-7.5 cells were a kind gift from Charles Rice (The Rock-
efeller University, New York, NY). SGR cells were previously described
(Blight et al., 2002). 293Tcells were purchased from ATCC (CRL-11268).
Antibodies
HSC70 (Santa Cruz Biotech, sc-7298), HSP70 (Santa Cruz Biotech,
sc-66048), mouse IgG (Santa Cruz Biotech, sc-2025), Alexa Fluor 647-
conjugated donkey anti-mouse IgG (HþL) (Life Technologies, A31571),
Alexa Fluor 594-conjugated donkey anti-rabbit IgG (HþL) (Jackson
ImmunoResearch, 711-585-152), and tubulin (abcam, ab6160).
Coimmunoprecipitation
Huh-7.5 cells were infected for 72 h and harvested. Subse-
quently, the lysates from infected and control uninfected cells
were utilized for coimmunoprecipitation assays with antibody
against HSC70 and mouse IgG as negative control. Coimmunopre-
cipitations were done using Protein A/G PLUS-Agarose (Santa Cruz
Biotech, sc-2003) according to manufacturer's instructions.
Immunoﬂuorescence
Huh-7.5 cells were grown on glass cover slips and infected for
48 h. Subsequently, cells were brieﬂy rinsed with PBS, ﬁxed for
15 min at room temperature with 4% paraformaldehyde in PBS, pH
7.4, permeabilized for 3 min at room temperature with 0.1% Triton
X-100 and 1% 2.5 M sucrose in PBS, and blocked for 1 h at room
temperature with 10% serum in PBS, pH 7.4. Then cells were
washed with PBS and incubated with antibodies against HSC70
(1:100) and NS5A (1:100) in 1% BSA in PBS for 2 h. After washing,
the cells were double stained with Alexa Fluor 647- and Alexa
Fluor 594-conjugated secondary antibodies.
Confocal microscopy
The cover slips prepared above were mounted on microscope
slides with VECTASHIELD Mounting Medium (Vector Laboratories,
H-1000), and immunoﬂuorescence was detected by a Leica TCS
SP2-FILM confocal microscope. Colocalization was analyzed with
ImageJ v1.47v software according to software instructions.
RNA interference
siRNAs against HSC70 (Santa Cruz Biotech, sc-29349) and HSP70
(Thermo Scientiﬁc, M-005168-01-0005) as well as Control siRNA-A
(Santa Cruz Biotech, sc-37007) and siGENOME Non-Targeting siRNA
Pool #2 (Thermo Scientiﬁc, D-001206-14-05) were transfected into
huh-7.5 cells using Lipofectamine 2000 Transfection Reagent (Life
Technologies, 11668-019) according to manufacturer's instructions.
shRNAs against HSC70 (Santa Cruz Biotech, sc-29349-SH) and
HSP70 (Santa Cruz Biotech, sc-29352-SH) as well as control shRNA
plasmid-A (Santa Cruz Biotech, sc-108060) were transfected into
huh-7.5 cells using X-tremeGene 9 DNA Transfection Reagent
(Roche, 6365779001) according to manufacturer's instructions.
Cell viability
Cell viability was determined using MTT Cell Proliferation assay
(ATCC, 30-1010K) according to manufacturer's instructions.
Densitometry
Western blot images were analyzed by ImageJ v1.47v software
according to software instructions.
Infectious virus production
pFNX-RLuc was in vitro transcribed, and the puriﬁed RNA was
electroporated into huh-7.5 cells to generate infectious viral
supernatant as previously described (Arumugaswami et al., 2008).
Viral assays
The HCV reporter virus was utilized as described previously
(Khachatoorian et al., 2012a). All infection assays were performed
with a viral titer of 103 focus forming units and a multiplicity of
infection (MOI) of 0.1. Intracellular virus production: huh-7.5 cells
were infected for 3 h at which point the mediumwas replaced and
infection was allowed to proceed. Cells were harvested 48 h later,
and luciferase activity was measured using the Renilla Luciferase
Assay System (Promega, E2820). Intracellular viral protein produc-
tion: huh-7.5 cells were infected for 3 h at which point the
medium was replaced and infection was allowed to proceed. Cells
were harvested at the indicated time points, and luciferase activity
was measured. Infectious virion secretion: (1) Long term assay: the
supernatants from the above cultures were used to infect naïve
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cells for 3 h at which point the mediumwas replaced and infection
was allowed to proceed. Cells were harvested 48 h after infection,
and Renilla luciferase activity was measured. (2) Short term assay:
supernatants were removed from original cultures, cells were
washed with PBS, and fresh medium was added. Five hours later,
the supernatants were collected and used to infect naïve cells for
3 h at which point the medium was replaced. Cells were harvested
72 h after infection, and luciferase activity was measured. Intra-
cellular infectious virion assembly: huh-7.5 cells were infected for
3 h at which point the medium was replaced and infection was
allowed to proceed. Supernatants were removed 24 h after infec-
tion, cells were washed with PBS, and fresh medium was added.
The cultures were subjected to three cycles of freeze–thaw to
release assembled viral particles. These suspensions were cleared
of cellular debris and used to infect naïve cells for 3 h at which
point the medium was replaced and infection was allowed to
proceed. Cells were harvested 72 h after infection, and luciferase
activity was assayed.
Quantitative reverse-transcriptase PCR
Huh-7.5 cells, plated in 10 cm plates, were treated with siRNAs
against HSC70, HSP70 or the corresponding control siRNAs.
Twenty-four hours after transfection, cells were infected with
the Renilla reporter virus. Twenty-four hours after infection, cells
were harvested, and total RNA was extracted using RNeasy Mini
Kit (Qiagen, 74104). cDNA was synthesized using iScript cDNA
Synthesis Kit (Bio-Rad, 1708891). Quantitative PCR was performed
using the Applied Biosystems 7500 Fast Real-Time PCR System
with 2x SYBR Green Master Mix (Diagenode, GMO-SG2x-A300) in
25 mL reactions. The real-time PCR cycling conditions were 50 1C
for 2 min and 95 1C for 10 min, followed by 40 cycles at 95 1C for
15 s, 60 1C for 30 s and 72 1C for 30 s each as well as a ﬁnal
dissociation stage of 95 1C for 15 s and 60 1C for 1 min. The primers
for the viral genome were derived from the 5'-non-coding region
and were CTGGGTCCTTTCTTGGATAA and CCTATCAGGCAGTACCACA.
HCV RNA levels were normalized to the housekeeping gene actin
using the primers CCAACCGCGAGAAGATGA and CCAGAGGCGTACA-
GGGATAG.
IRES reporter assay
293T cells were treated with siRNAs against HSC70, HSP70, or
the corresponding control siRNAs. Twenty-four hours after siRNA
transfection, cells were transfected with the HCV IRES reporter
plasmid and either pMSCV-NS5A-FLAG or pMSCV-GFP. All trans-
fections were done using X-tremeGene 9 Transfection Reagent
(Roche, 06365779001). Seventy-two hours post-transfection, Renilla
and Fireﬂy luciferase activity were determined using Dual Luciferase
Assay System (Promega, E1910).
Statistical analysis
Error bars reﬂect the standard deviation. P values were deter-
mined by the Student t test. All viral assays were done with six
biological replicates for each individual assay.
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